Favourable response to infliximab in a case of bilateral refractory Mooren's ulcer
- PMID: 18173422
- DOI: 10.1111/j.1442-9071.2007.01609.x
Favourable response to infliximab in a case of bilateral refractory Mooren's ulcer
Abstract
A woman with progressive bilateral Mooren's ulcer developed recurrent corneal perforations and melting requiring tectonic grafts, despite conventional immunosuppressant therapy. Following treatment with infliximab, an anti-tumour necrosis factor agent, the patient showed marked reduction in conjunctival inflammation and no further recurrence of corneal thinning and perforation during 2-year follow up on maintaining treatment.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
